CTI Offered CTI Coaching Phase 2

---

June 22, 2017

After a thorough evaluation of SunRegen’s business plan, Swiss Commission for Technology and Innovation (CTI) decided to offer CTI coaching phase 2 to SunRegen. CTI coach Dr. Andreas J. Schulze started to provide professional coaching support for SunRegen.

The SunRegen CTI Coaching Phase 2 program supports the SBC003 team with professional mentorship, strategic guidance, and access to industry expertise. Additionally, after a thorough evaluation of SunRegen’s business plan, the Swiss Commission for Technology and Innovation (CTI) offered the company Phase 2 coaching. Dr. Andreas J. Schulze provides personalized coaching. He helps the team refine its strategy, optimize research processes, and plan for clinical development.

By participating in SunRegen CTI Coaching, the team gains critical insights into regulatory pathways, commercialization strategies, and investor engagement. Furthermore, the program connects SunRegen with other innovative biotech startups. This fosters collaboration, knowledge sharing, and networking opportunities. In addition, these connections enhance SunRegen’s visibility in the European healthcare ecosystem and attract potential partnerships and funding.

The CTI Coaching Phase 2 program includes workshops, hands-on training, and ongoing support. Moreover, it enables SunRegen to strengthen operational efficiency and accelerate its mission to develop therapies for neurodegenerative disorders. By applying lessons from the program, SunRegen ensures that its research aligns with industry standards. It also addresses patient needs effectively.

For more information, explore SunRegen research initiatives to learn about ongoing projects. Also, SunRegen’s participation in CTI Coaching Phase 2 demonstrates the company’s commitment to innovation, scientific excellence, and translating research into practical therapies.